As of June 30, 2026, Lotte Chemical Corporation carries a market capitalization of 2.70T, placing it among publicly traded companies globally. Its enterprise value stands at 13.37T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.70T |
| Enterprise Value | 13.37T |
Lotte Chemical Corporation's next confirmed earnings release is scheduled for November 6, 2026.
| Earnings Date | 11/6/2026 |
As of June 30, 2026, Lotte Chemical Corporation has 42.17M shares outstanding.
| Shares Outstanding | 42.17M |
These figures are as of June 30, 2026. The price-to-sales ratio is 0.13, and the price-to-book ratio stands at 0.20.
| PS Ratio | 0.13 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.25 |
| P/FCF Ratio | -1.62 |
| P/OCF Ratio | -4.17 |
As of June 30, 2026, Lotte Chemical Corporation trades at an EV/EBITDA multiple of 14.18 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.66 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 13.37T versus a market cap of 2.70T, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.66 |
| EV / EBITDA | 14.18 |
As of June 30, 2026, Lotte Chemical Corporation maintains a current ratio of 1.14, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 56.49, indicating elevated leverage, while an interest coverage ratio of 1.89 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.14 |
| Quick Ratio | 0.63 |
| Debt / Equity | 56.49 |
| Debt / EBITDA | 11.11 |
| Interest Coverage | 1.89 |
Over the twelve months ended June 30, 2026, Lotte Chemical Corporation posted a negative return on equity (ROE) of -8.79, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.54, reflecting losses generated across the asset base. The company generates approximately 4.53B in revenue per employee across its workforce of 4,452.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.07 indicates how many times Lotte Chemical Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -8.79 |
| Return on Assets (ROA) | -3.54 |
| Revenue Per Employee | 4.53B |
| Employee Count | 4,452.75 |
| Inventory Turnover | 6.07 |
Over the twelve months ended June 30, 2026, Lotte Chemical Corporation recorded an income tax benefit of -138.81B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -1.67T and -1.17T in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -138.81B |
As of the close on October 23, 2026, Lotte Chemical Corporation's stock has declined approximately 35.46% over the past 52 weeks. The 50-day moving average sits at 58,747.00, while the 200-day moving average is 72,746.75.
| 52-Week Price Change | -35.46% |
| 50-Day Moving Average | 58,747.00 |
| 200-Day Moving Average | 72,746.75 |
Over the twelve months ended June 30, 2026, Lotte Chemical Corporation generated 20.17T in revenue and converted that into -1.17T in net income, yielding earnings per share of -36,383.62. EBITDA reached 943.06B, while operating income came in at -382.12B.
| Revenue | 20.17T |
| Gross Profit | 860.65B |
| Operating Income | -382.12B |
| Pretax Income | -1.67T |
| Net Income | -1.17T |
| EBITDA | 943.06B |
| EBIT | -382.41B |
| Earnings Per Share (EPS) | -36,383.62 |
As of June 30, 2026, Lotte Chemical Corporation holds 5.01T in cash and equivalents against 10.48T in total debt, resulting in a net debt position of 8.84T. Total book value stands at 13.33T, with working capital of 1.12T providing operational flexibility.
| Cash & Cash Equivalents | 5.01T |
| Total Debt | 10.48T |
| Net Debt | 8.84T |
| Equity (Book Value) | 13.33T |
| Book Value Per Share | 316,159.36 |
| Working Capital | 1.12T |
Lotte Chemical Corporation produced -647.34B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.02T in capital expenditures, free cash flow totaled -1.67T - equivalent to -39,551.33 per share.
| Operating Cash Flow | -647.34B |
| Capital Expenditures | -1.02T |
| Free Cash Flow | -1.67T |
| FCF Per Share | -39,551.33 |
Over the twelve months ended June 30, 2026, Lotte Chemical Corporation posted a gross margin of 4.27, reflecting its pricing power and cost economics. The operating margin of -1.89 and net profit margin of -5.81 provide insight into operational efficiency.
| Gross Margin | 4.27 |
| Operating Margin | -1.89 |
| Pretax Margin | -8.29 |
| Profit Margin | -5.81 |
| EBITDA Margin | 4.67 |
Over the twelve months ended June 30, 2026, Lotte Chemical Corporation paid dividends of 500.00 per share. The dividend payout ratio of -1.11 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -61.80: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 11.02, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Lotte Chemical Corporation shareholders.
| Dividend Per Share | 500.00 |
| Payout Ratio | -1.11 |
| Shareholder Yield | 11.02 |
| FCF Yield | -61.80 |
Lotte Chemical Corporation's most recent stock split took place on December 14, 2022 with a 211:220 split ratio.
| Last Split Date | 12/14/2022 |
| Split Ratio | 211:220 |
As of June 30, 2026, Lotte Chemical Corporation has an Altman Z-Score of 1.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.22 |
Already premium?